pubmed-article:11031083 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0037929 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0026473 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C2697752 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0024432 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0021701 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0003209 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C0600210 | lld:lifeskim |
pubmed-article:11031083 | lifeskim:mentions | umls-concept:C1515999 | lld:lifeskim |
pubmed-article:11031083 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:11031083 | pubmed:dateCreated | 2000-11-17 | lld:pubmed |
pubmed-article:11031083 | pubmed:abstractText | The inflammatory response that ensues during the initial 48 to 72 h after spinal cord injury causes considerable secondary damage to neurons and glia. Infiltration of proinflammatory-activated neutrophils and monocytes/macrophages into the cord contributes to spinal cord injury-associated secondary damage. beta2 integrins play an essential role in leukocyte trafficking and activation and arbitrate cell-cell interactions during inflammation. The beta2 integrin, alphaDbeta2, is expressed on monocytes/macrophages and neutrophils and binds to vascular adhesion molecule-1 (VCAM-1). The increased expression of VCAM-1 during central nervous system (CNS) inflammation likely contributes to leukocyte extravasation into the CNS. Accordingly, blocking the interaction between alphaDbeta2 and VCAM-1 may attenuate the inflammatory response at the SCI site. We investigated whether the administration of monoclonal antibodies (mAbs) specific for the rat alphaD subunit would reduce the inflammatory response after a spinal cord transection injury in rats. At a 1 mg/kg dose two of three anti-alphaD mAbs caused a significant ( approximately 65%) reduction in the number of macrophages at the injury site and one anti-alphaD mAb led to a approximately 43% reduction in the number of neutrophils at the SCI site. Thus, our results support the concept that the alphaDbeta2 integrins play an important role in the trafficking of leukocytes to a site of central nervous system inflammation. This study also offers preliminary evidence that anti-alphaD mAbs can reduce the extravasation of macrophages and, to a lesser extent, neutrophils, to the SCI site. | lld:pubmed |
pubmed-article:11031083 | pubmed:language | eng | lld:pubmed |
pubmed-article:11031083 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11031083 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11031083 | pubmed:month | Nov | lld:pubmed |
pubmed-article:11031083 | pubmed:issn | 0014-4886 | lld:pubmed |
pubmed-article:11031083 | pubmed:author | pubmed-author:WeaverL CLC | lld:pubmed |
pubmed-article:11031083 | pubmed:author | pubmed-author:DekabanG AGA | lld:pubmed |
pubmed-article:11031083 | pubmed:author | pubmed-author:MabonP JPJ | lld:pubmed |
pubmed-article:11031083 | pubmed:copyrightInfo | Copyright 2000 Academic Press. | lld:pubmed |
pubmed-article:11031083 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11031083 | pubmed:volume | 166 | lld:pubmed |
pubmed-article:11031083 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11031083 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11031083 | pubmed:pagination | 52-64 | lld:pubmed |
pubmed-article:11031083 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:meshHeading | pubmed-meshheading:11031083... | lld:pubmed |
pubmed-article:11031083 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:11031083 | pubmed:articleTitle | Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment. | lld:pubmed |
pubmed-article:11031083 | pubmed:affiliation | The Neurodegeneration Research Group, The John P. Robarts Research Institute, London, Ontario, N6A 5K8, Canada. | lld:pubmed |
pubmed-article:11031083 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11031083 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11031083 | lld:pubmed |